Morgan Stanley (NYSE:MS) issued its quarterly earnings data on Wednesday. The financial services provider reported $0.81 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.18. Morgan Stanley had a net margin of 13.27% and a return on equity of 6.41%.

Shares of Morgan Stanley (NYSE:MS) opened at 32.32 on Wednesday. The stock has a 50 day moving average of $31.90 and a 200 day moving average of $28.37. Morgan Stanley has a 1-year low of $21.16 and a 1-year high of $35.74. The company has a market cap of $61.79 billion, a price-to-earnings ratio of 14.95 and a beta of 2.09.

Earnings History for Morgan Stanley (NYSE:MS)

A number of equities analysts recently commented on the stock. Barclays PLC reaffirmed a “hold” rating on shares of Morgan Stanley in a research report on Saturday, July 9th. Deutsche Bank AG reaffirmed a “hold” rating on shares of Morgan Stanley in a research report on Sunday, June 26th. Vetr raised shares of Morgan Stanley from a “sell” rating to a “hold” rating and set a $26.38 price target on the stock in a research report on Wednesday, July 13th. RBC Capital Markets set a $32.00 price target on shares of Morgan Stanley and gave the stock a “buy” rating in a research report on Thursday, July 21st. Finally, Berenberg Bank assumed coverage on shares of Morgan Stanley in a research report on Wednesday, July 13th. They set a “hold” rating and a $29.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and fourteen have issued a buy rating to the stock. Morgan Stanley currently has an average rating of “Hold” and an average target price of $32.59.

In other Morgan Stanley news, insider Jeffrey S. Brodsky sold 19,955 shares of the company’s stock in a transaction that occurred on Thursday, July 21st. The stock was sold at an average price of $28.79, for a total value of $574,504.45. Following the completion of the sale, the insider now owns 123,710 shares of the company’s stock, valued at $3,561,610.90. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, COO James A. Rosenthal sold 91,426 shares of the company’s stock in a transaction that occurred on Monday, July 25th. The stock was sold at an average price of $29.06, for a total value of $2,656,839.56. Following the completion of the sale, the chief operating officer now directly owns 270,880 shares of the company’s stock, valued at approximately $7,871,772.80. The disclosure for this sale can be found here. 0.35% of the stock is owned by company insiders.

A number of hedge funds have recently modified their holdings of the company. Euclid Advisors LLC purchased a new stake in shares of Morgan Stanley during the second quarter valued at about $270,000. Nuveen Fund Advisors LLC purchased a new stake in shares of Morgan Stanley during the second quarter valued at about $311,000. Mariner Wealth Advisors LLC purchased a new stake in shares of Morgan Stanley during the second quarter valued at about $322,000. Rosenblum Silverman Sutton S F Inc. CA purchased a new stake in shares of Morgan Stanley during the second quarter valued at about $613,000. Finally, Ameritas Investment Partners Inc. raised its stake in shares of Morgan Stanley by 3.4% in the second quarter. Ameritas Investment Partners Inc. now owns 29,869 shares of the financial services provider’s stock valued at $776,000 after buying an additional 996 shares in the last quarter. 83.82% of the stock is owned by institutional investors and hedge funds.

Morgan Stanley Company Profile

Morgan Stanley is a financial holding company. The Company is a global financial services firm that, through its subsidiaries and affiliates, advises, and originates, trades, manages and distributes capital for, governments, institutions and individuals. Its segments include Institutional Securities, Wealth Management and Investment Management.

5 Day Chart for NYSE:MS

Receive News & Stock Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related stocks with our FREE daily email newsletter.